Separation of virus particles with ligating filter elements
Ligating polymers with hydrophobic quaternary ammonium groups enhance the separation of full and empty AAVs by increasing salt tolerance and conductivity windows, addressing inefficiencies in current methods and ensuring safer gene therapy treatments.
Patent Information
- Application Number
- PCT/US2025/056033
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-11-19
- Filing Date
- 2025-11-19
- Publication Date
- 2026-05-28
AI Technical Summary
Current methods for separating full adeno-associated viruses (AAVs) from empty AAVs are inefficient due to their identical shape and size, leading to low salt tolerance and unclear separation windows, which increases the risk of adverse side effects in gene therapy treatments.
Development of ligating polymers with hydrophobic quaternary ammonium groups that bind to the internal hydrophobic amino acids of AAVs, allowing for higher salt tolerance and a wider conductivity window for separation, enabling clear distinction between full and empty AAVs.
The new filter elements provide improved salt tolerance and separation efficiency, reducing the need for additional salt removal steps and ensuring safer gene therapy treatments by minimizing impurities.
Smart Images

Figure IMGF000013_0001 
Figure IMGF000013_0002 
Figure IMGF000029_0001